Microparticles and Exosomes: Are They Part of Important Pathways in Sepsis Pathophysiology? by Luciano C. P. Azevedo
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
7 
Microparticles and Exosomes: Are They  
Part of Important Pathways in  
Sepsis Pathophysiology? 
Luciano C. P. Azevedo 
Research and Education Institute, Hospital Sírio-Libanês and  
University of São Paulo School of Medicine 
Brazil 
1. Introduction 
Microparticles are a heterogeneous population of small membrane-coated vesicles released 
by several cell lines upon activation or apoptosis. Microparticles generation seems to be a 
well regulated process, although these vesicles are highly variable in size, composition and 
function. Despite being previously considered inert debris without specific function, recent 
data demonstrated important pathophysiological mechanisms orchestrated by 
microparticles in vascular diseases associated with endothelial dysfunction. These vesicles 
have been implicated, among others, in the pathogenesis of thrombosis, inflammation, 
atherosclerosis and vascular cell proliferation. In addition to microparticles, activation of the 
endocytic-lisosomal cellular system of circulating cells induce the release of smaller vesicles 
denominated exosomes that can also participate in vascular derangement. This role of 
microparticles and exosomes in mediating vascular dysfunction suggests that they may 
represent novel pathways in short or long-distance paracrine transcellular signaling in 
vascular environment. The mechanisms involved in the origin of microparticles and 
exosomes, their composition and participation in the pathogenesis of sepsis will be 
discussed in this review. 
2. Origin of microparticles 
Circulating cells in vascular environment as well as endothelial cells after activation or 
apoptosis are capable of releasing membranous fragments (vesicles), of size varying from 
100 nm to 1000 nm (Fig. (1)). These vesicles present, on their surfaces, at least some of the 
antigenic markers of the parent cell (Azevedo et al., 2007). The first description of these 
vesicles was made in 1967, with the reports of a “platelet dust” (platelet membrane 
fragments) in human plasma (Wolf et al., 1967). After a more precise characterization on 
their origin, composition and function, these vesicles were called microparticles (or 
microvesicles) and there is now increasing evidence for their role in transcellular 
communication in microvascular environment. However, the precise functions of these 
fragments and their interaction with cells in vasculature remain incomplete. 
The release of microparticles has been described in several circumstances in normal 
physiology as well as in disease states. In health, it has been reported that 80% of 
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circulating microparticles express membrane antigens that suggest a platelet origin. These 
vesicles have also been implicated to play a role in inflammation, coagulation and 
diseases associated with impairment of vascular function, e.g. atherosclerosis, diabetes 
and hypertension (Tushuizen et al., 2011). Usually, microparticles release is the result of 
cell activation or apoptosis, although it is not known whether these events lead to the 
formation of similar microparticles, in terms of size, lipid and protein composition and 
pathophysiological effects. Microparticles release is an integral part of the membrane-
remodeling process in which the asymmetric distribution of constitutive phospholipids 
between the two leaflets of the cell membrane is lost, with released microparticles 
exposing phosphatidylserine in the outer membrane, which acts as a template for  
the prothrombinase complex assembly and for their role in coagulation activation (Zwaal 
& Schroit, 1997).  
 
 
Fig. 1. Microparticles (arrows) isolated from plasma of a patient 24 hours after percutaneous 
coronary angioplasty. Electron micrography depicts a heterogeneous population of vesicles 
ranging in size from 80 to 200 nm (original magnification X39000). Adapted from Azevedo 
et al., 2007 with permission. 
It is important to note, in first place, that circulating microparticles are a population of 
vesicles from different cell types and from different cellular compartment origins. As 
already discussed, the most common mechanism of microparticle release is cell activation or 
apoptosis, which induces plasma membrane budding, leading to the formation of 
membrane blebs. However, apoptosis can also induce the formation of apoptotic bodies, 
which are sometimes considered as members of microparticles’ family. Apoptotic bodies are 
cell fragments many times larger in diameter and volume than microparticles that are 
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consequence of cell fragmentation in the final stages of apoptosis, in contrast with 
microparticles, that are released in the early moments of programmed cell death. These 
apoptotic bodies also expose phosphatidylserine in the outer membrane, but unlike 
microparticles, have poor prothrombotic properties. Probably, the role of 
phosphatidylserine in these corpuscles is to recruit phagocytic cells to the site of apoptotic 
death (Janiszewski et al, 2004). 
Other type of vesicle released after cell activation that can sometimes overlap microparticle 
function is the exosome. Dissimilar to microparticles that are fragments of cell membranes, 
exosomes are vesicles produced in the endocytic-lysosomal system of several cell lines. 
Exosomes are smaller than microparticles (usually less than 0.1 µm), have different surface 
antigens and poor clotting capacity (Azevedo et al, 2007). The role of exosomes in sepsis will 
be discussed in more details below. 
Virtually all cell types subjected to activation can release microparticles after blebbing of 
plasma membrane. The most common cell types associated with microparticle release are 
platelets, endothelial cells, neutrophils, smooth muscle cells, monocytes and T lymphocytes. 
(Azevedo et al, 2007). Their ubiquity has suggested a more general role for microparticles in 
cellular regulation, possibly with functions reminiscent of their original cell. 
3. Composition of microparticles 
The membrane of microparticles, which is derived from the parental cell plasma membrane, 
consists primarily of lipids and proteins, in variable amounts. The precise content of lipids 
and proteins is dependent on the cell they originate from and the type of stimulus involved 
in their formation.  
Microparticles are surrounded by a phospholipid bilayer. During the budding process, the 
normal phospholipid asymmetry of the membrane is lost, with microparticles exposing 
negatively charged phospholipids such as phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) in their outer membrane leaflet. Exposure of PS plays a role 
in the in vivo effects of microparticles, since PS is an efficient site for coagulation factor 
activation. Analysis of components of microparticles from blood of healthy donors indicates 
that phosphatidylcholine represents more than 60% of their lipid content (Weerheim et al, 
2002). Other lipids present in minor concentrations are sphingomyelin, PS and PE.  
Although these microparticles are in the vast majority derived from platelets (~75%), their 
phospholipid composition is different from parental cell. 
Protein composition in the surface of microparticles is dependent of parental cell type. These 
surface antigens are specific for the cell they originate from and can help to identify the 
origin of microparticle. However, microparticle can differ in the expression of cell surface 
molecules from their parental cells. This is particularly important when microparticles 
express molecules upregulated or translocated by cell activation or apoptosis. For example, 
IL-1 alpha-activated cultured endothelial cells can release microparticles displaying E-
selectin and endothelial cell adhesion molecule 1 in significantly higher concentrations than 
resting cultivated endothelial cells (Abid Hussein et al, 2003). There are also data depicting 
different protein composition of microparticles in response to different agonists and with 
the same parental cell stimulated with the same agonist (Hughes et al, 2000). Taken together, 
these differences indicate that shedding seems to be a well-regulated process that originates 
unique microparticle characteristics depending on the cell source, stimulus, scenario and 
pathophysiological conditions. 
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More recent data demonstrate that, besides proteins and lipid composition on the surface of 
microparticles, the inner portion of these vesicles also contain several enzymes and genetic 
material capable of interacting and producing effects on the target cell (Meziani et al, 2010). 
Subunits of enzymes with superoxide producing activity like NADPH oxidase have  
been identified on microparticles originated from platelets (Janiszewski et al, 2004). In 
addition, microparticles and exosomes from cultured cells and normal individuals have 
been demonstrated to contain mRNA and microRNA, which suggests that these vesicles 
may play a role on the cell to cell transfer of genetic contents (Hunter et al, 2008 and  
Valadi et al,  2007). 
4. Mechanisms of microparticle release 
Platelets release microparticles after activation by thrombin, ADP plus collagen, calcium 
ionophore A23187 and high shear stress. Endothelial cells, monocytes and vascular smooth 
cells can release microparticles after activation by bacterial lipopolysaccharide, 
inflammatory cytokines, complement complex C5b-9 or reactive oxygen species (Boulanger 
et al, 2006). 
The mechanisms governing plasma membrane shedding and consequent microparticle 
release are only partially understood. Usually, the shedding starts within minutes after 
addition of an agonist, by a calcium-dependent process that can be blocked by calcium 
chelators. One of the possible molecules governing this process is calpain µ, which is a 
calcium-dependent cytosolic-protease that cleaves talin and α-actin. Inhibition of calpain 
by calpeptin or calcium chelators prevents the release of microparticles (Azevedo et al, 
2007). However, molecules other than calpain may be involved in calcium-dependent 
microparticles release, since blockade by calpeptin did not induce an inhibition of 
microparticle release to the same extent as EGTA, suggesting a role for other calcium 
dependent processes. Cytosolic calcium increase may also activate kinases and inhibit 
phosphatases, which together with calpain activation, are responsible for cytoskeleton 
disruption. Membrane skeleton disruption is the result of several mechanisms, such  
as myosin light-chain phosphorylation mediated by myosin light-chain kinase (MLCK) 
upon activation or Rho-associated kinase I (ROCK-I), in apoptosis. Phosphorilation of 
myosin light chains (MLC) stimulates the contractile activity of myosin, with myosin 
ATPase activation creating movement between actin and myosin filaments (Azevedo  
et al, 2007). This movement may tensionate plasma membrane and cause detachment  
of the cytoskeleton from the membrane, with the formation of blebs and the subsequent 
release of microparticles. However, the precise interaction between cell membrane  
and cytoskeleton, which permits microparticle formation, is still unknown. Recent data 
has implicated ROCK-II (an isoform of ROCK-I) in thrombin-induced microparticle 
release from endothelial cells. These new data recently incorporated indicates that the 
knowledge on mechanisms inducing cytoskeleton rearrangement during bleb formation is 
still scarce.   
Another important feature in microparticle formation is the loss of phospholipid asymmetry 
of membranes after cell activation. Usually, PS and PE are specifically segregated in the 
inner leaflet, whereas phosphatidylcholine and sphingomyelin are enriched in the external 
one. This distribution is controlled by three enzymes: an inward-directed pump, a flippase 
(aminophospholipid translocase), specific for PS and PE; an outward-directed pump 
referred to as "floppase"; and a lipid scramblase, promoting unspecific bidirectional 
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redistribution across the bilayer. The increase in calcium content after cell activation may 
lead to collapse of the membrane asymmetry by stimulating scramblase and floppase 
activities and concomitantly inhibiting the flippase. The increase in PS exposure in the outer 
leaflet that follows microparticle formation enhances coagulative properties and facilitates 
removal of apoptotic bodies by phagocytic cells. PS also binds annexin-5, which has been 
used in several studies for microparticle quantification (Azevedo et al, 2007).   
Whether microparticles release is the result of cell membrane shedding, the release of 
exosomes from the parental cell is mainly orchestrated by the endocytic-lisossomal 
system. Endocytosis is a range of processes performed by the cell in order to internalize 
specific regions of the plasma membrane as well as small amounts of extracellular fluid. 
In this process, intracellular compartments of endocytic pathway called multivesicular 
bodies (MVB) composed of numerous vesicles are able to fuse with the plasma membrane, 
releasing these vesicles abroad. After incorporation into the cell, the absorbed material is 
accumulated in endosomes, which are major sites of entry for the captured molecules.  
The endosomes then become MVB, which are characterized by being more spherical,  
had lower intra-luminal pH and a different protein distribution. It is unclear the 
mechanism by which endosomes become MVB. In MVB, the presence of vesicular bodies 
inside is better characterized and once formed, these structures are destined for several 
processes: they can serve as storage sites; They can direct proteins to be degraded through 
their fusion with lysosomes (organelles that constitute, together with the MVB, the major 
site of protein and lipid degradation in the cell); Or they can fuse with the plasma 
membrane, thereby releasing their vesicles (exosomes) into the extracellular medium 
(Azevedo et al, 2007).  
5. Microparticles in inflammatory conditions and sepsis 
There is now emerging evidence that microparticles and exosomes participate actively in 
regulation of vascular function in several healthy and disease states. Microparticles, 
regardless their cell origin, can transfer biological information between cells, therefore 
acting as vectors of signaling molecules. Most of the exchange of information from 
microparticles takes place at the level of endothelium and contributes to their 
(patho)physiological role. Microvesicles (microparticles and exosomes) have been reported 
to be part of the disease mechanisms in several conditions, such as inflammation, 
thrombosis and vascular dysfunction, all elements that are reported to be extremely 
involved in the pathogenesis of sepsis. 
It is now demonstrated from in vitro and in vivo studies that microparticles may play a role 
in inflammatory conditions, since they display a variety of proinflammatory activities. 
Microparticles from endothelial cells, platelets and leukocytes can promote adhesion and 
rolling of leukocytes, contain proinflammatory cytokines and trigger the release of 
microparticles from several cell types in vitro (Huber at el, 2002, Forlow et al, 2000). In 
addition, oxidized phospholipids from endothelial microparticles released by oxidative 
stress may cause monocyte adherence to endothelial cells and neutrophil activation (Huber 
et al, 2002). A recent study demonstrated also that microparticles isolated from septic shock 
patients injected into rats induce the expression of inducible nitric oxide synthase, nuclear 
factor kappa B and cyclooxygenase-2 in the lungs and hearts of these animals (Mastronardi 
et al, 2011). 
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Besides endothelial microparticles, other vesicles released from different cell sources may 
have a role in mediating cellular interactions in vascular milieu. Platelet-derived 
microparticles, for instance, can enhance the binding of neutrophils to other neutrophils 
under flow conditions. This effect seems to be mediated by an interaction between P-selectin 
on microparticles and P-selectin-glycoprotein ligand 1 on neutrophils, since the blockade of 
these surface molecules can reduce this binding (Forlow et al, 2000).  Microparticles derived 
from platelets can also stimulate monocyte-endothelial interactions, by delivering 
arachidonic acid to endothelial cells, which induces the upregulation of expression of 
cellular adhesion molecules (ICAM-1) on endothelium and CD11a/CD18 and CD11b/CD18 
on monocytes (Barry et al, 1998).  
Platelet-derived microparticles, as well as vesicles from other cell lines, can contribute to 
inflammation by stimulating the production of several cytokines. Microparticles derived 
from leukocytes can increase the production of IL-6, monocyte chemotactic protein 1 (MCP-
1) and Tissue Factor (TF) in endothelial cells (Mesri & Altieri, 1999). Platelet-derived 
microparticles have been associated with increased production of IL-8, IL-1beta and TNF-
alpha by a monocytic cell line (THP-1) and endothelial cells in high shear stress conditions 
(Nomura et al, 2004).  In leukocytes, endotoxin stimulation induced the shedding of 
microvesicles containing platelet-activating factor (PAF), a known inducer of inflammatory 
response (Watanabe et al, 2003). 
Evidence that microparticles participate in the genesis of inflammatory diseases is 
supported by studies that depicted increased number of microparticles in inflammatory 
conditions in vivo. Meningococcal sepsis, for instance, is associated with increased levels of 
microparticles released mainly from granulocytes and platelets (Nieuwland et al, 2000). 
These vesicles are highly procoagulant, which demonstrates the correlation among 
inflammation and coagulation in the pathogenesis of several vascular diseases. In patients 
with sepsis and multiple organ dysfunction syndrome, Joop et al found increased number of 
microparticles released from granulocytes, and diminished levels of microparticles derived 
from platelets and erythrocytes were also found. Trauma patients have also increased levels 
of leukocyte microparticles with enhanced expression of adhesion molecules on days 2 to 5 
after injury (Fujimi et al, 2003). In addition, in sepsis, circulating levels of endothelial and 
platelet microparticles were negatively correlated with unfavorable outcomes during 
multiple organ dysfunction syndrome (Soriano et al, 2005). 
Sepsis has also been associated with significant endothelial dysfunction. Many studies 
have isolated microparticles from blood of patients with disease states marked by 
vascular dysfunction, and these vesicles were associated with this impairment in isolated 
arteries (Martin et al, 2004, Tesse et al 2005). Microparticles released from T-lymphocytes 
are capable of impairing endothelial function after 12 or 24 hours of incubation, also 
decreasing eNOS expression and increasing caveolin-1 expression of endothelial cells in 
culture (Martin et al, 2004). Another investigation reported impairment of vascular 
function with microparticles released from an apoptotic T cell line in a mechanism 
associated with transcription factor NF-κB production and proinflammatory protein 
upregulation (Tesse et al, 2005). Microparticles originated from endothelial cells in culture 
induce superoxide production by aortic rings associated with impairment of 
acethylcoline-induced vasorelaxation. These microvesicles also inhibit NO production by 
aortic rings and display p22(phox), a subunit of superoxide-producing enzyme NADPH 
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oxidase, thus demonstrating an important role for oxidative stress in vascular dysfunction 
(Brodsky et al, 2004). However, there is still a lot to be discovered on the mechanisms of 
microparticles induced endothelial dysfunction.  
Another hallmark of sepsis is activation of coagulation. The most known property of 
microparticles is their ability to induce coagulation activation with subsequent thrombosis 
of vascular beds. There is substantial in vitro evidence of the involvement of microparticles 
in activation of coagulation system (Muller et al, 2003). In vivo studies depicting increased 
concentrations of microparticles in diseases associated with coagulation activation 
corroborate the in vitro data (Nieuwland et al, 2000). 
Circulating microparticles provide an additional procoagulant phospholipid surface for the 
assembly of the clotting enzymes complexes that promote thrombin generation.  The 
assembly of vitamin-K dependent tenase and prothrombinase complexes in microparticles is 
known as platelet factor 3 activity. Platelet microparticles also display activated factor V in 
their surface, which may contribute to activation of clotting. Endothelial microparticles, in 
turn, released after stimulation of endothelial cells in culture with plasminogen activator 
inhibitor-1 (PAI-1) become procoagulant with an accelerated thrombin production (Brodsky 
et al, 2002). This activation of coagulation that occurs after microparticle release culminates 
with the generation of thrombin, which consequently induces hemostasis or a 
prothrombotic state. The stimulation of clotting that follows microparticle release requires a 
tight control exerted by natural anticoagulant systems. Indeed, binding of protein S to 
microparticle surface has already been described, with subsequent binding of protein C and 
activated protein C.  
A more direct mechanism relating microparticles and initiation of coagulation was 
described when TF was reported to be present in the surface of platelet-derived 
microvesicles (Muller et al, 2003). TF has also been described in microparticles derived from 
monocytes and smooth muscle cells after apoptosis (Azevedo et al, 2007). Moreover, 
microparticles are capable of inducing TF expression on monocytes (Sturk-Maquelin et al, 
2003). Since TF mRNA has not been demonstrated in megakaryocytes, platelet-derived and 
microparticles-derived TF is likely to originate from other cell lines, incorporated in platelets 
by transcelular exchange (Scholz et al, 2002). Tissue factor production in microparticles has 
also been associated with inflammatory conditions such as meningococcal disease 
(Nieuwland et al, 2000), thus demonstrating the continuous interplay between inflammation 
and coagulation activation.  
The evidence for microparticle contribution to coagulation in vivo is circumstantial. There 
are reports of increase in microparticle numbers in several diseases associated with 
hypercoagulation such as heparin induced thrombocytopenia and acute coronary 
syndromes. Moreover, several diseases related with hypercoagulation are associated with 
production of microparticles exposing TF, such as disseminated intravascular coagulation 
((Nieuwland et al, 2000). This demonstrates a probable role of microparticles as contributors 
of vascular dysfunction in cardiovascular diseases and sepsis.  
6. Exosomes are a special type of microparticles 
Exosomes are frequently referred as a specialized category of microparticles with specific 
functions in immune response and protein sorting. They are released mainly from antigen 
presenting cells, although exosomes have been identified after platelet (Heijnen et al, 1999) 
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and mast cell (Denzer et al, 2000) activation and in body fluids, such as urine (Zhou et al, 
2006) or bronchoalveolar lavage (Admyre et al, 2003).  Dissimilar to microparticles, 
exosomes are more homogeneous in size (diameters ranging from 60 to 100 nm) and 
composition, and are enriched in tetraspaning proteins (Azevedo et al, 2007). They are also 
derived from endocytic-lisosomal cellular system, whereas microparticles are fragments of 
plasmatic membrane. Platelet-derived exosomes display PS in a much less extent than 
microparticles, thus they are poor coagulation activators (Heijnen et al, 1999). However, 
they exhibit major histocompatibility complex (MHC) class I or II molecules in their surface, 
which demonstrate their role in antigen presentation (Théry et al, 2002). Common filtration 
and centrifugation processes used to separate microparticles frequently cannot eliminate 
these small particles. Thus, some of the biologic effects of microparticles observed in  
the literature may be due to the presence of exosomes in the preparation. The major 
differences between microparticles and exosomes regarding origin and composition are 
described in table 1. 
 
Property Microparticles Exosomes 
Origin Plasma Membrane Endocytic-lisosomal system 
Type of Generation Regulated Constitutive 
Mechanism of Release Shedding from plasma 
membrane 
Exocytosis of MVB 
Intracellular Storage No Yes 
Protein Composition Annexin 2, caspases CD9, CD63, cytokines, 
Integrins 
Lipid Composition Cholesterol Cheramides, cholesterol 
Table 1. Main differences between microparticles and exosomes 
The role of exosomes in sepsis remains deeply unexplored. One previous study from our 
laboratory identified in septic patients’ plasma exosomes derived predominantly from 
platelets. These vesicles have been associated with vascular dysfunction of sepsis, due to 
their effects in inducing apoptosis of endothelial cells and vascular smooth muscle cells in 
culture, in a mechanism mediated by oxidative stress (Janiszewski et al, 2004; Gambim et al, 
2007). They display components of NADPH oxidase in their membrane and are capable of 
production of reactive oxygen species per se (Janiszewski et al, 2004; Gambim et al, 2007). In 
addition, these vesicles may induce contractile dysfunction in isolated hearts as well as in 
isolated papillary muscle preparations. This dysfunction is enhanced by previous treatment 
of the animals with LPS and the mechanism associated is probably NO-mediated (Azevedo 
et al, 2007). Thus, in a condition associated with severe vascular dysfunction such as sepsis, 
exosomes may play a role in regulating cardiovascular function.  
7. Conclusions  
In this review we have assessed the current knowledge on microparticles formation, 
composition and function, as well as their role in sepsis. Accumulating data suggest that 
these microvesicles play a role in inflammation, thrombosis and vascular dysfunction, three 
pathways clearly involved in the pathogenesis of sepsis. Additional studies that clarify the 
composition of these vesicles as well as the underlying mechanisms involved in their effects 
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will probably help in the development of additional interventional strategies for prevention 
and treatment of sepsis.  
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